1. Assessment of COVID-19 lockdown effect on early Alzheimer Disease progression

   • Carmen Peña-Bautista
   • Lourdes Álvarez-Sánchez
   • Consuelo Cháfer-Pericás

   Original Communication 28 July 2023 Pages: 4585 - 4592

   

2. Pediatric de novo movement disorders and ataxia in the context of SARS-CoV-2

   • Nina-Maria Wilpert
   • Ana Luísa de Almeida Marcelino
   • Marc Nikolaus

   Review Open access 29 July 2023 Pages: 4593 - 4607

   

3. Delirium in hospitalized COVID-19 patients: a prospective, multicenter, cohort study

   • Wei Zhu
   • Yangjing Bai
   • Yan Jiang

   Original Communication 30 July 2023 Pages: 4608 - 4616

   

4. Central nervous system complications in SARS-CoV-2-infected patients

   • Zhonggui Li
   • Danyu Lin
   • Enxiang Tao

   Original Communication Open access 13 August 2023 Pages: 4617 - 4631

   

5. Risk of breakthrough COVID-19 after vaccination among people with multiple sclerosis on disease-modifying therapies

   • Ronen Spierer
   • Idit Lavi
   • Daniel Golan

   Original Communication 17 August 2023 Pages: 4632 - 4639

   

6. Characterizing long-COVID brain fog: a retrospective cohort study

   • Grace Y. Lam
   • Ronald W. Damant
   • Maeve P. Smith

   Original Communication 09 August 2023 Pages: 4640 - 4646

   

7. A hypoarousal model of neurological post-COVID syndrome: the relation between mental fatigue, the level of central nervous activation and cognitive processing speed

   • Eva Maria Martin
   • Sven Rupprecht
   • Kathrin Finke

   Original Communication Open access 25 June 2023 Pages: 4647 - 4660

   

8. Longitudinal analysis and treatment of neuropsychiatric symptoms in post-acute sequelae of COVID-19

   • Emilie N. Liu
   • Jennifer H. Yang
   • Jennifer S. Graves

   Original Communication 26 July 2023 Pages: 4661 - 4672

   

9. Neurological symptoms after COVID-19 vaccination: a report on the clinical presentation of the first 50 patients

   • Ameli Gerhard
   • Vanessa Raeder
   • Christiana Franke

   Short Commentary Open access 29 July 2023 Pages: 4673 - 4677

10. Association between vaccination and the risk of central demyelination: results from a case-referent study

    • Lamiae Grimaldi-Bensouda
    • Caroline Papeix
    • Lucien Abenhaim

    Original Communication Open access 23 June 2023 Pages: 4678 - 4686

    

11. Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study

    • Maria Pia Amato
    • Roberto Bergamaschi
    • Maria Trojano

    Original Communication Open access 05 July 2023 Pages: 4687 - 4696

    

12. Functional connectivity modifications in monoaminergic circuits occur in fatigued MS patients treated with fampridine and amantadine

    • Maria A. Rocca
    • Paola Valsasina
    • Massimo Filippi

    Original Communication 18 July 2023 Pages: 4697 - 4706

    

13. Frequency of demyelinating disease activity following immune checkpoint inhibitor cancer immunotherapy

    • Shemonti Hasan
    • Onilia Zorio
    • Cristina Valencia-Sanchez

    Letter to the Editors 19 August 2023 Pages: 4707 - 4712

    

14. Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis

    • Hongyuan Chu
    • Xinyu Zhang
    • Xu Yang

    Review Open access 28 June 2023 Pages: 4713 - 4728

    

15. The safety and effectiveness of high-calorie therapy for treating amyotrophic lateral sclerosis: a systematic review and meta-analysis

    • Qiaochu Zhu
    • Dandan Xu
    • Yan Zhao

    Review Open access 28 June 2023 Pages: 4729 - 4743

    

16. Determining ICU EEG periodic patterns and why it matters

    • Philippe Gélisse
    • William O. Tatum
    • Peter W. Kaplan

    Review Open access 01 July 2023 Pages: 4744 - 4752

    

17. Serum levels of neurofilament light chains in pediatric multiple sclerosis: a systematic review and meta-analysis

    • Alexandru-Ştefan Niculae
    • Lucia-Elena Niculae
    • Vitalie Văcăraş

    Review 02 July 2023 Pages: 4753 - 4762

    

18. Diagnosis and management of Becker muscular dystrophy: the French guidelines

    • Armelle Magot
    • Karim Wahbi
    • The French BMD working group

    Review 09 July 2023 Pages: 4763 - 4781

    

19. Efficacy and safety of noninvasive brain stimulation for patients with cerebellar ataxia: a systematic review and meta-analysis of randomized controlled trials

    • Cheng Gong
    • Yi Long
    • Yun Luo

    Review 17 July 2023 Pages: 4782 - 4799

    

20. Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing–remitting multiple sclerosis

    • Igal Rosenstein
    • Markus Axelsson
    • Jan Lycke

    Original Communication Open access 14 June 2023 Pages: 4800 - 4811

    

21. Fatigue in stroke survivors: a 5-year follow-up of the Fall study of Gothenburg

    • Lior Schnitzer
    • Per-Olof Hansson
    • Carina U. Persson

    Original Communication Open access 15 June 2023 Pages: 4812 - 4819

    

22. Frailty in aneurysmal subarachnoid hemorrhage: the risk analysis index

    • Alis J. Dicpinigaitis
    • Syed Faraz Kazim
    • Christian A. Bowers

    Original Communication 17 June 2023 Pages: 4820 - 4826

    

23. Magnetic resonance neurography and diffusion tensor imaging of the sciatic nerve in hereditary transthyretin amyloidosis polyneuropathy

    • Roberto Gasparotti
    • Alessandro Salvalaggio
    • Chiara Briani

    Original Communication Open access 17 June 2023 Pages: 4827 - 4840

    

24. Brain FDG-PET correlates of saccadic disorders in early PSP

    • G. Pin
    • J. Labouré
    • L. Koric

    Original Communication 18 June 2023 Pages: 4841 - 4850

    

25. Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson’s disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial

    • Chloé Laurencin
    • Noémie Timestit
    • Stéphane Thobois

    Original Communication Open access 20 June 2023 Pages: 4851 - 4859

    

26. Autoimmune glial fibrillary acidic protein astrocytosis mimicking tuberculous meningitis: a retrospective study

    • Yingfang Liang
    • Gangqi Wang
    • Hao Zeng

    Original Communication Open access 20 June 2023 Pages: 4860 - 4867

    

27. The impact of upper and lower motor neuron burden on diagnostic certainty, and clinical course of spinal-onset amyotrophic lateral sclerosis: a cluster-based approach

    • Giammarco Milella
    • Stefano Zoccolella
    • Giancarlo Logroscino

    Original Communication 20 June 2023 Pages: 4868 - 4875

    

28. Physical fitness moderates the association between brain network impairment and both motor function and cognition in progressive multiple sclerosis

    • Penelope Tilsley
    • Isanbert Arun Strohmeyer
    • Jan-Patrick Stellmann

    Original Communication 21 June 2023 Pages: 4876 - 4888

    

29. Correction to: Physical fitness moderates the association between brain network impairment and both motor function and cognition in progressive multiple sclerosis

    • Penelope Tilsley
    • Isanbert Arun Strohmeyer
    • Jan-Patrick Stellmann

    Correction 26 July 2023 Pages: 4889 - 4889

30. Epileptogenicity of white matter lesions in cerebral small vessel disease: a systematic review and meta-analysis

    • Jakob I. Doerrfuss
    • Jonas M. Hebel
    • Martin Holtkamp

    Original Communication Open access 21 June 2023 Pages: 4890 - 4902

    

31. Establishing normative data for the evaluation of cognitive performance in Huntington’s disease considering the impact of gender, age, language, and education

    • Alžbeta Mühlbäck
    • Josef Mana
    • the REGISTRY investigators of the European Huntington’s Disease Network, the Enroll-HD investigators

    Original Communication Open access 22 June 2023 Pages: 4903 - 4913

    

32. Risk characteristics of alcohol and/or drug misuse in repeat emergency department attendees for seizures: a case–control study

    • Sarah Lennard
    • William Henley
    • Rohit Shankar

    Original Communication 24 June 2023 Pages: 4914 - 4921

    

33. Economic evaluation of Motor Neuron Diseases: a nationwide cross-sectional analysis in Germany

    • Felix Heinrich
    • Isabell Cordts
    • Olivia Schreiber-Katz

    Original Communication Open access 25 June 2023 Pages: 4922 - 4938

    

34. Brain MRI correlations with disease burden and biomarkers in Fabry disease

    • Yawen Zhao
    • Ying Zhu
    • Yining Huang

    Original Communication Open access 25 June 2023 Pages: 4939 - 4948

    

35. Genetic risk factors of Alzheimer’s Disease disrupt resting-state functional connectivity in cognitively intact young individuals

    • Ludmila Kucikova
    • Jianmin Zeng
    • Li Su

    Original Communication Open access 26 June 2023 Pages: 4949 - 4958

    

36. The genetic and clinical spectrum in a cohort of 39 families with complex inherited peripheral neuropathies

    • Mengli Wang
    • Honglan Yang
    • Ruxu Zhang

    Original Communication 26 June 2023 Pages: 4959 - 4967

    

37. Autonomic dysfunction is associated with disease progression and survival in amyotrophic lateral sclerosis: a prospective longitudinal cohort study

    • Raffaele Dubbioso
    • Vincenzo Provitera
    • Maria Nolano

    Original Communication Open access 26 June 2023 Pages: 4968 - 4977

    

38. Synergistic effects of vagus nerve stimulation and antiseizure medication

    • Yaroslav Winter
    • Katharina Sandner
    • Sergiu Groppa

    Original Communication Open access 27 June 2023 Pages: 4978 - 4984

39. A typology of cerebral small vessel disease based on imaging markers

    • Christoph Sperber
    • Arsany Hakim
    • Roza Umarova

    Original Communication Open access 27 June 2023 Pages: 4985 - 4994

    

40. The added value of spinal cord lesions to disability accrual in multiple sclerosis

    • Serena Ruggieri
    • Luca Prosperini
    • Carlo Pozzilli

    Original Communication Open access 29 June 2023 Pages: 4995 - 5003

    

41. Study of the relationship between onset lateralization and hemispheric white matter asymmetry in Parkinson's disease

    • Yuxia Zhu
    • Sichen Li
    • Lifen Chen

    Original Communication 29 June 2023 Pages: 5004 - 5016

    

42. Incidence and prevalence of Spinal and bulbar muscular atrophy in South Korea: a nationwide population-based study

    • Jin-Mo Park
    • Minsung Kang
    • Jin-Sung Park

    Original Communication 30 June 2023 Pages: 5017 - 5022

    

43. Predictors of acute ischemic cerebral lesions in immune-mediated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

    • Lisa Neuman
    • Adrien Joseph
    • the participants to the Prospective Multicenter MATRISK study

    Original Communication 01 July 2023 Pages: 5023 - 5033

    

44. Acute pediatric encephalitis: etiology, course, and outcome of a 12-year single-center immunocompetent cohort

    • Giacomo Brisca
    • Chiara Marini
    • Maria Margherita Mancardi

    Original Communication 03 July 2023 Pages: 5034 - 5047

    

45. Epilepsy associated with cerebral cavernous malformations managed with stereotactic radiosurgery: an international, multicenter study

    • Chloe Dumot
    • Georgios Mantziaris
    • Jason P. Sheehan

    Original Communication 05 July 2023 Pages: 5048 - 5056

    

46. A new genetic cause of spastic ataxia: the p.Glu415Lys variant in TUBA4A

    • Annalaura Torella
    • Ivana Ricca
    • Alessandro Filla

    Original Communication Open access 07 July 2023 Pages: 5057 - 5063

    

47. Combined genotype of HCRTR2 and CLOCK variants in a large family of cluster headache with familial periodicity phenotype

    • Cyprian Popescu

    Original Communication 07 July 2023 Pages: 5064 - 5070

    

48. The rising role of cognitive reserve and associated compensatory brain networks in spinocerebellar ataxia type 2

    • Libera Siciliano
    • Giusy Olivito
    • Maria Leggio

    Original Communication Open access 08 July 2023 Pages: 5071 - 5084

    

49. Satralizumab as a treatment for pediatric-onset neuromyelitis optica spectrum disorder with cluster attack: a case report

    • Rui Wang
    • Dongren Sun
    • Hongyu Zhou

    Letter to the Editors 19 May 2023 Pages: 5085 - 5089

    

50. Parkinson’s disease in a patient with olfactory hypoplasia: a model case of “body-first Lewy body disease” providing insights into the progression of α-synuclein accumulation

    • Tomoyasu Matsubara
    • Shigeo Murayama
    • Yuko Saito

    Letter to the Editors 29 May 2023 Pages: 5090 - 5093